Session 17 - Decentralization - The Good, The Bad and The Ugly

  • #explore
Tuesday, September 15, 2020: 11:15 AM - 12:15 PM
/ CEU Credits:0.2

SESSION CHAIRS & SPEAKERS

Speaker
Ednah Awiti
Data Coordinator II
Phastar Limited
Session Chair
Lisa Squibb
Sr. Associate Director, CDM
Boehringer Ingelheim
Speaker
Yvette Colon
Principal Clinical Data Manager
Boehringer Ingelheim

SESSION DESCRIPTION 

This session will include two presentations surrounding experiences with decentralization in their clinical trials. The presenters will highlight the decentralization process used by each, what worked, what didn't and some lessons learned to take forward into future decentralized trials.


TOPIC


LEARNING OBJECTIVES

1. What are decentralized trials?
2. What are some pros?
3. What are some cons?
4. What can we learn moving forward?

SESSION INFORMATION

CDM Certification Competencies::
Electronic Data Collection,Data Base Updates,Clinical Database Design/Relational Data Bases

Target Audience:
Clinical Operations,Data Management,Biostatistics